RxDoctor Payments Data

Megan Jack

Plastic Surgery · Knoxville, TNNPI 1093934341

Payments from drug & device makers

What this record shows

AbbVie accounts for 62.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $4,223 and has fallen 87.3% since, to $535 in 2025.

$7,038in general payments, 2019–2025

Across 105 payments — averaging $67.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Mentor Worldwide LLC$1K
  • Sientra, Inc.$329
  • Motiva USA, LLC$300
  • Revance Therapeutics, Inc.$114
  • Avita Medical Americas, LLC$55
  • plus $461 from 16 others

What the payments were for

  • Travel & lodging$3,18445%
  • Food & beverage$3,85455%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,038 in reported general payments places this provider in the 70th percentile of 89 plastic surgery providers in Tennessee.

See all plastic surgery providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron11$38

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →